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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Iron is an essential metallic microelement for life. However, iron
overload is toxic. The liver serves an important role as a store 
house for iron in the body. About 20–25 mg of iron is required
each day for hemoglobin synthesis. To maintain iron homeostasis,
transferrin and transferrin receptors are primarily involved in the
uptake of iron into hepatocytes, ferritin in its storage, and ferro 
portin in its export. Moreover, hepcidin controls ferroportin and
plays a central role in the iron metabolism. Excess “free” reactive
iron produces damaging free radicals via Fenton or Harber Weiss
reactions. Produced free radicals attack cellular proteins, lipids
and nucleic acid. Several detoxification system and anti oxidant
defense mechanisms exist to prevent cellular damage by free
radicals. Excessive free radicals can lead to hepatocellular damage,
liver fibrosis, and hepatocarcinogenesis.
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Introduction Iron is the most abundant metallic microelement in the body,
and it performs important actions in the body; being essential
in hemoglobin synthesis for new erythrocytes (oxygen transport
and delivery),(1) enzymes involving electron transport, iron-sulfur
proteins,(2,3) and so on. The total amount of iron in the bodies of
adult human males is about 5 g, of which approximately 65% is
hemoglobin iron in erythrocytes.(1) The remainder is stored in
ferritin in the liver and other organs.(4,5) Some iron is also present
as myoglobin iron in muscles, heme iron in enzymes involved
in respiration in all cells and drug metabolism. Daily food intake
contains approximately 10 mg of iron, of which 1–2 mg is
absorbed by the mucosa of the upper small intestine, bound to
transferrin (Tf) in blood, and transported throughout the body
as diferric transferrin (Fe2-Tf). Iron homeostasis is maintained
by the loss of about 1 mg of iron per day through the sloughing of
intestinal mucosa and skin. However, 20–25 mg of iron is required
each day for the hemoglobinization of new erythrocytes, for which
iron in senescent erythrocytes, largely processed in reticulo-
endothelial cells, such as macrophages, is reused. As there appears
to be no developed mechanism to evacuate accumulated iron from
the body, excess iron intake can easily lead to iron overload in
tissues, producing free radicals. This article provides an overview
of iron metabolism in the liver, particularly in hepatocytes, and the
production of free radicals caused by iron overload in the liver.
Iron in Hepatocytes
Iron absorbed from food in the upper small intestine is first
transported to the liver via the portal vein. The liver not only stores
iron, but also plays a crucial role in iron metabolism, such as in the
production of Tf, iron carrier protein, and hepcidin known as a
hormone that functions in the regulation of iron metabolism.
Mechanisms of iron transport into hepatocytes. Extra-
cellular circulating iron in the plasma is present as soluble Tf-
bound iron, and when there is excess iron, as non-transferrin-
bound iron (NTBI), which is bound to serum proteins, such as
albumin or citric acid.(6,7) Hepatocytes express both transferrin
receptor (TfR) 1 and a homolog, TfR2.(8) Under neutral pH condi-
tions, Tf binds two iron atoms with high affinity, and are circulated
in the blood as Fe2-Tf.(9) Known routes for the import of Fe2-Tf
into hepatocytes are via TfR1(10,11) and TfR2,(8) and a TfR-
independent route.(12,13)
Fe2-Tf binds with TfR1 on the cell membrane surface and forms
a complex that is then taken up into hepatocytes by endocytosis.(14)
Mice lacking TfR1 die during mid-gestation from reduction in
erythrocyte sell size and hemoglobin content, an indication of its
physiological essentiality.(15) TfR1 expression is controlled by the
excess or deficiency of iron within cells, and is regulated by
interactions between trans-acting iron regulatory proteins (IRP1
and IRP2) and multiple iron-responsive elements (IREs) present in
the 3'-untranslated regions (UTRs) of TfR1 mRNA (The IRP-IRE
regulatory system).(16–18) When there is insufficient iron, IRP binds
with multiple IREs in the 3' UTR of TfR1 mRNA, and TfR1
protein levels increase via stabilization of the mRNA. In a state of
excess iron, on the other hand, IRP is released from multiple
IREs.(19) Thus, IRP acts as a sensor protein for intracellular iron
and regulates the expression of IRE genes (Fig. 1A).
Once the Fe2-Tf/TfR1 complex is endocytosed, the pH of endo-
somes is lowered to 5–6 by a proton pump ATPase.(20) The Fe2-Tf
bond is broken within acidic endosomes, and Fe3+ (ferric iron) is
released within the endosome.(21) The free Fe3+ in endosomes then
becomes Fe2+ (ferrous iron) by enzymes of the six-transmembrane
epithelial antigen of the prostate (STEAP) family,(22,23) and sub-
sequently transported to the cytoplasm by divalent metal trans-
porter 1 (DMT1, also known as Nramp2 or DCT1), a member of
the NRAMP (natural resistance-associated macrophage protein)
family of metal iron transporters.(24,25) Much of the iron transported
into the cytoplasm is employed in reactions for essential physio-
logical reactions, such as mitochondrial adenosine triphosphate
(ATP) generation, TCA cycle, and DNA damage repair.(26) Mean-
while, unused iron is stored in the iron-binding protein, ferritin.
After dissociating from iron, apo-Tf and TfR1 return to the cell
membrane surface, and are reused for further iron binding and
uptake (Fig. 2 A–F).(21)
TfR2 was discovered in 1999 as a molecule highly homologous
with the TfR1 gene,(8) and it was later shown that mutations in
human TfR2 gene induced iron overload syndrome,(27) consistent
with its important role in iron metabolism. TfR2 protein is
distributed on the basolateral membrane of hepatocytes, and like
the TfR1 protein, binds specifically to Tf.(28) IRE is not present in
TfR2 mRNA; thus, its mRNA expression is almost completely
unaffected by iron levels.(29) Nevertheless, when there is excess
iron, Fe2-Tf stabilizes the TfR2 protein, resulting in increased
TfR2 protein levels.(30,31)
There are also reports of a route for the import of iron into
hepatocytes that is not mediated by TfRs (Fig. 2G),(12,32) and the
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involvement of DMT1(13) and the zinc transporter ZIP14 (Zrt-Irt-
like protein 14)(33) molecules in the uptake of NTBI. In especially
cardiomyocytes, it has been reported that L-type voltage-
dependent calcium channels involved in the uptake of NTBI under
iron overload condition.(34)
Iron storage in hepatocytes. Hepatocytes have a large
capacity for iron storage. After iron’s entering hepatocytes, the
portion that is not used is stored in the cores of ferritin shells, in
order to prevent subsequent toxicity.(35) When hepatocytes become
heavily iron overload, an insoluble hemosiderin is derived from
iron-rich ferritin.(5) Ferritin is an iron-storage protein comprising
heavy (H) and light (L) subunits.(36) Fe2+ is oxidized to Fe3+ by
ferroxidase in the H subunit, and then Fe3+ is stored in spaces
within ferritin.(37) The synthesis of ferritin, like the TfR protein, is
also regulated by IRP protein binding in the mRNA IRE region,
and when the concentration of iron in cells increases, the amount
of ferritin protein increases.(38,39) As some of the ferritin in the
cell cytoplasm is secreted into extracellular medium, it can be
measured in clinical tests to gauge the amount of iron stored in
the body under non-inflammation conditions.
Regulation of iron export from hepatocytes. There is
only 4 mg of iron in blood, and stored iron must be sent quickly
Fig. 1. The IRP IRE regulatory system. A: Regulation of TfR1; at the high level of iron, the IRPs binding with multiple IREs in the 3' UTRs of TfR1
mRNA promotes TfR1 mRNA’s translation via mRNA stabilization. B: Regulation of ferritin; the IRP binding with the single IRE in the 5' UTRs of ferri 
tin mRNA blocks the translation of ferritin message. In iron overload, the IRP contained the Fe S cluster cannot bind with the IRE in the 5' UTRs of
ferritin mRNA, resulting in the increased translation of ferritin message.
Fig. 2. Iron metabolism in hepatocytes. A–F: TfR dependent route (the Tf cycle). A: Two ferric irons (Fe3+) in the plasma bind to Tf with high
affinity. B: Fe2 Tf binds to TfR1 on the surface of hepatocytes. C: Fe2 Tf/TfR1 complex is taken up into hepatocytes by endocytosis. D: The pH of
endosomes is lowered to 5–6 by an action of proton pumps, and then Fe3+ is released at this acidic pH. E: Released Fe3+ becomes ferrous iron (Fe2+)
by the enzymes of STEAP family, and then Fe2+ moves across the endsomal membrane through the DMT1 transporter. F: Apo Tf still binds to TfR1 at
the lower pH of endosomes. Apo Tf/TfR1 is returned to the surface of the hepatocyte for further iron binding and uptake. G: TfR independent
route. At the high level of iron in plasma, NTBI is reduced to Fe2+ by ferric reductase. Fe2+ is rapidly transported into the hepatocytes through DMT1. J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 105
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to the blood in order to maintain serum iron concentrations.
Some kinds of cells, hepatocytes, intestinal epithelial cells and
macrophages, have mechanisms to export iron. Iron is exported
from cells by the ferroportin membrane protein (also known as
IREG1 or MTP1),(40) and it is reported that in mice or Zebrafish
lacking ferroportin, the supply of iron to the blood is almost
entirely lost.(41) Iron sent into the blood is again transferred to Tf
and is used in erythrocyte production in bone marrow. The expres-
sion of ferroportin is also regulated by the IRP-IRE regulatory
system and hepcidin,(42) which is currently thought to play a central
role in the iron metabolism.(43–46)
Hepcidin is synthesized in hepatocytes, secreted from hepato-
cytes, and excreted through the kidneys.(43,47) Hepcidin in its
mature form is a 25-amino acid-peptide, hepcidin-25.(47) Hepcidin-
25 binds with ferroportin and both are broken down in lysosomes
by endocytosis.(46,48) Hepcidin-25 expression decreases and ferro-
portin iron export is promoted, when the body requires more
serum iron, such as iron deficiency, hypoxia, and pregnancy.(47,49–50)
However, in iron deficiency anemia in states of chronic inflam-
mation, the supply of iron to the blood is inhibited by the reduced
ferroportin function. It is thought that the inflammatory cytokine,
interleukin-6 (IL-6), induces the expression of hepcidin-25 in
hepatocytes, resulting in decreased ferroportin.(49,51) And when
serum iron is not needed, hepcidin-25 expression increases and
ferroportin is broken down, restricting the supply of iron.(47,49)
Iron Overload and Free Radicals
In healthy individuals, almost all of the iron in circulating blood
is bound to Tf, while those in hepatocytes is bound to ferritin
and isolated.(35) Ferritin has the capacity to hold 2,000–5,000 iron
ions per a molecule, and as mentioned above, the amount of
ferritin protein expressed increases with elevated intracellular
levels of iron by the IRP-IRE regulatory system (Fig. 1B).(39)
Ferritin can therefore handle even high amounts of iron imported
into hepatocytes.(52) However, during iron overload, ferritin that
is bound with iron undergoes denaturation in lysosomes to become
hemosiderin, and Fe2+ is released from NTBI that is not bound to
ferritin. When this occurs, Fe2+ reacts with hydrogen peroxide
(H2O2) to generate hydroxyl radical (￿OH) which have the highest
toxicity among reactive oxygen species (ROS), via the Fenton
reaction or Harber-Weiss reaction. And Fe2+ also reacts with lipid
peroxides to generate lipid radicals. These radicals oxidize various
cell components; including lipid membranes, proteins, and DNA,
causing apoptosis or other cell damage.(53) The solubility of iron
ions in the cytoplasm is very low; thus, they are assumed to be
bound with other molecules, such as adenosine diphosphate
(ADP), rather than be present as single ions. This notion is
supported by the fact that administration of the iron chelating
agent deferoxamine almost completely suppresses the cell damage
from free radicals.(54,55) The risk of hepatocellular carcinoma
(HCC) from hereditary hemochromatosis (HH) is about 200 times
higher than that in healthy individuals. Interestingly, excess
deposits of iron are also seen in hepatic tissues in chronic hepatitis
C patients. It has been reported that chronic hepatitis C patients
and hepatitis C virus (HCV) transgenic mice have lower levels
of hepcidin, consistent with iron accumulation in the liver.(56–58)
In such chronic hepatitis C patients, 8-hydroxydeoxy-guanosine
(8-OHdG), an indicator of DNA damage by ROS, is significantly
higher.(59) On the other hand, the rate of HCC from chronic hepatitis
C patients treated with phlebotomy is significantly lower.(60) More-
over, it has been reported that the supplementation of exogenous
antioxidants (vitamins A and E) reduced 8-OHdG levels in dietary
iron overloaded rats.(61) These evidences in vivo and in vitro
studies suggest that iron overload in the cytoplasm contributes,
through the production of ROS, to both cellular damage and
hepatocarcinogenesis.
Conclusions
Various molecules are involved in iron transport, storage, and
export in hepatocytes, and because iron intake tends to be
insufficient, despite being essential for life activity, systems for the
reuse of iron have evolved. However, in states of iron overload
from excess iron intake or chronic inflammation, harmful ROS are
produced, and these may be able to cause hepatocellular damage
and hepatocarcinogenesis.
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Abbreviations
Tf transferrin
Fe2-Tf diferric transferrin
NTBI non-transferrin-bound iron
TfR transferrin receptor
IRP iron regulatory proteins
IRE iron-responsive element
UTRs untranslated regions
STEAP six-transmembrane epithelial antigen of the prostate
DMT1 divalent metal transporter 1
NRAMP natural resistance-associated macrophage protein
ATP adenosine triphosphate
ZIP Zrt-Irt-like protein
IL interleukin
H2O2 hydrogen peroxide
ROS reactive oxygen species
ADP adenosine diphosphate
HCC hepatocellular carcinoma
HH hereditary hemochromatosis
HCV hepatitis C virus
8-OHdG 8-hydroxydeoxy-guanosine
References
1 Wilson MT, Reeder BJ. Oxygen-binding haem proteins. Exp Physiol 2008;
93: 128–132.
2 Rouault TA, Tong WH. Iron-sulphur cluster biogenesis and mitochondrial
iron homeostasis. Nat Rev Mol Cell Biol 2005; 6: 345–351.
3 Lill R, Mühlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: compo-
nents and mechanisms. Annu Rev Cell Dev Biol 2006; 22: 457–486.
4 Harrison PM, Arosio P. The ferritins: molecular properties, iron storage
function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161–203.
5 Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function
relationships, synthesis, degradation and secretion. Arch Physiol Biochem
2007; 113: 30–54.
6 Silva AM, Hider RC. Influence of non-enzymatic post-translation modifica-
tions on the ability of human serum albumin to bind iron. Implications for
non-transferrin-bound iron speciation. Biochim Biophys Acta 2009; 1794:
1449–1458.
7 Silva AM, Kong X, Parkin MC, Cammack R, Hider RC. Iron(III) citrate
speciation in aqueous solution. Dalton Trans 2009; 28: 8616–8625.
8 Kawabata H, Yang R, Hirama T, and et al. Molecular cloning of transferrin
receptor 2. A new member of the transferrin receptor-like family. J Biol Chem
1999; 274: 20826–20832.
9 Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Effective
binding of free iron by a single intravenous dose of human apotransferrin in
haematological stem cell transplant patients. Br J Haematol 2002; 119: 547–
553.
10 Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 2004; 36: 2137–2143.
11 Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: moleculardoi: 10.3164/jcbn.10 76
©2011 JCBN
106
control of mammalian iron metabolism. Cell 2004; 117: 285–297.
12 Ikuta K, Zak O, Aisen P. Recycling, degradation and sensitivity to the
synergistic anion of transferrin in the receptor-independent route of iron
uptake by human hepatoma (HuH-7) cells. Int J Biochem Cell Biol 2004; 36:
340–352.
13 Shindo M, Torimoto Y, Saito H, and et al. Functional role of DMT1 in
transferrin-independent iron uptake by human hepatocyte and hepatocellular
carcinoma cell, HLF. Hepatol Res 2006; 35: 152–162.
14 Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF. Kinetics of
internalization and recycling of transferrin and the transferrin receptor in a
human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem
1983; 258: 9681–9689.
15 Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is
necessary for development of erythrocytes and the nervous system. Nat Genet
1999; 21: 396–399.
16 Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an
update. Ann NY Acad Sci 2004; 1012: 1–13.
17 Rouault TA. The role of iron regulatory proteins in mammalian iron
homeostasis and disease. Nat Chem Biol 2006; 2: 406–414.
18 Cairo G, Recalcati S. Iron-regulatory proteins: molecular biology and patho-
physiological implications. Expert Rev Mol Med 2007; 9: 1–13.
19 Wang W, Di X, D’Agostino RB, Jr., Torti SV, Torti FM. Excess capacity of
the iron regulatory protein system. J Biol Chem 2007; 282: 24650–24659.
20 Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR.
Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.
Proc Natl Acad Sci USA 1983; 80: 2263–2266.
21 Dautry-Varsat A, Ciechanover A, Lodish HF. pH and the recycling of trans-
ferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 1983;
80: 2258–2262.
22 Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J.
Identification of a ferrireductase required for efficient transferrin-dependent
iron uptake in erythroid cells. Nat Genet 2005; 37: 1264–1269.
23 Sendamarai AK, Ohgami RS, Fleming MD, Lawrence CM. Structure of the
membrane proximal oxidoreductase domain of human Steap3, the dominant
ferrireductase of the erythroid transferrin cycle. Proc Natl Acad Sci USA
2008; 105: 7410–7415.
24 Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews
NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for
Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998; 95:
1148–1153.
25 Ludwiczek S, Theurl I, Muckenthaler MU, and et al.C a 2+ channel blockers
reverse iron overload by a new mechanism via divalent metal transporter-1.
Nat Med 2007; 13: 448–454.
26 Matsumoto Y, Zhang QM, Takao M, Yasui A, Yonei S. Escherichia coli Nth
and human hNTH1 DNA glycosylases are involved in removal of 8-
oxoguanine from 8-oxoguanine/guanine mispairs in DNA. Nucleic Acids Res
2001; 29: 1975–1981.
27 Camaschella C, Roetto A, Cali A, and et al. The gene TFR2 is mutated in a
new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25: 14–15.
28 Merle U, Theilig F, Fein E, and et al. Localization of the iron-regulatory
proteins hemojuvelin and transferrin receptor 2 to the basolateral membrane
domain of hepatocytes. Histochem Cell Biol 2007; 127: 221–226.
29 Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler
HP. Transferrin receptor 2-alpha supports cell growth both in iron-chelated
cultured cells and in vivo. J Biol Chem 2000; 275: 16618–16625.
30 Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2
protein stability. Blood 2004; 104: 4287–4293.
31 Johnson MB, Chen J, Murchison N, Green FA, Enns CA. Transferrin receptor
2: evidence for ligand-induced stabilization and redirection to a recycling
pathway. Mol Biol Cell 2007; 18: 743–754.
32 Sturrock A, Alexander J, Lamb J, Craven CM, Kaplan J. Characterization of
a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem
1990; 265: 3139–3145.
33 Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14)
mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci
USA 2006; 103: 13612–13617.
34 Oudit GY, Sun H, Trivieri MG, and et al. L-type Ca2+ channels provide a
major pathway for iron entry into cardiomyocytes in iron-overload cardio-
myopathy. Nat Med 2003; 9: 1187–1194.
35 Munro HN. Iron regulation of ferritin gene expression. J Cell Biochem 1990;
44: 107–115.
36 Boyd D, Jain SK, Crampton J, Barrett KJ, Drysdale J. Isolation and character-
ization of a cDNA clone for human ferritin heavy chain. Proc Natl Acad Sci
USA 1984; 81: 4751–4755.
37 Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr
2003; 133: 1549S–1553S.
38 Hentze MW, Caughman SW, Rouault TA, and et al. Identification of the
iron-responsive element for the translational regulation of human ferritin
mRNA. Science 1987; 238: 1570–1573.
39 Hentze MW, Rouault TA, Caughman SW, and et al. A cis-acting element is
necessary and sufficient for translational regulation of human ferritin expres-
sion in response to iron. Proc Natl Acad Sci USA 1987; 84: 6730–6734.
40 Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells.
Nature 2001; 414: 92–97.
41 Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S. The iron
exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab
2005; 1: 191–200.
42 Yeh KY, Yeh M, Glass J. Hepcidin regulation of ferroportin 1 expression in
the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol
2004; 286: G385–G394.
43 Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial
peptide synthesized in the liver. J Biol Chem 2001; 276: 7806–7810.
44 Nicolas G, Bennoun M, Devaux I, and et al. Lack of hepcidin gene expres-
sion and severe tissue iron overload in upstream stimulatory factor 2 (USF2)
knockout mice. Proc Natl Acad Sci USA 2001; 98: 8780–8785.
45 Loréal O, Brissot P. Hepcidin: the Grail of iron metabolism. Gastroenterol
Clin Biol 2002; 26: 805–807.
46 Nemeth E, Tuttle MS, Powelson J, and et al. Hepcidin regulates cellular iron
efflux by binding to ferroportin and inducing its internalization. Science 2004;
306: 2090–2093.
47 Pigeon C, Ilyin G, Courselaud B, and et al. A new mouse liver-specific gene,
encoding a protein homologous to human antimicrobial peptide hepcidin, is
overexpressed during iron overload. J Biol Chem 2001; 276: 7811–7819.
48 De Domenico I, Lo E, Ward DM, Kaplan J. Hepcidin-induced internalization
of ferroportin requires binding and cooperative interaction with Jak2. Proc
Natl Acad Sci USA 2009; 106: 3800–3805.
49 Nicolas G, Chauvet C, Viatte L, and et al. The gene encoding the iron
regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflamma-
tion. J Clin Invest 2002; 110: 1037–1044.
50 Millard KN, Frazer DM, Wilkins SJ, Anderson GJ. Changes in the expres-
sion of intestinal iron transport and hepatic regulatory molecules explain the
enhanced iron absorption associated with pregnancy in the rat. Gut 2004; 53:
655–660.
51 Nemeth E, Rivera S, Gabayan V, and et al. IL-6 mediates hypoferremia of in-
flammation by inducing the synthesis of the iron regulatory hormone hepci-
din. J Clin Invest 2004; 113: 1271–1276.
52 Miyazaki E, Kato J, Kobune M, and et al. Denatured H-ferritin subunit is a
major constituent of haemosiderin in the liver of patients with iron overload.
Gut 2002; 50: 413–419.
53 Um HD, Orenstein JM, Wahl SM. Fas mediates apoptosis in human mono-
cytes by a reactive oxygen intermediate dependent pathway. J Immunol 1996;
156: 3469–3477.
54 Sakaida I, Kyle ME, Farber JL. Autophagic degradation of protein generates
a pool of ferric iron required for the killing of cultured hepatocytes by an
oxidative stress. Mol Pharmacol 1990; 37: 435–442.
55 Sakaida I, Thomas AP, Farber JL. Increases in cytosolic calcium ion concen-
tration can be dissociated from the killing of cultured hepatocytes by tert-
butyl hydroperoxide. J Biol Chem 1991; 266: 717–722.
56 Fujita N, Sugimoto R, Takeo M, and et al. Hepcidin expression in the liver:
relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13:
97–104.
57 Nagashima M, Kudo M, Chung H, and et al. Regulatory failure of serum
prohepcidin levels in patients with hepatitis C. Hepatol Res 2006; 36: 288–293.
58 Nishina S, Hino K, Korenaga M, and et al. Hepatitis C virus-induced reactive
oxygen species raise hepatic iron level in mice by reducing hepcidin tran-
scription. Gastroenterology 2008; 134: 226–238.
59 Kato J, Kobune M, Nakamura T, and et al. Normalization of elevated hepatic
8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by
phlebotomy and low iron diet. Cancer Res 2001; 61: 8697–8702.
60 Kato J, Miyanishi K, Kobune M, and et al. Long-term phlebotomy with low-
iron diet therapy lowers risk of development of hepatocellular carcinoma
from chronic hepatitis C. J Gastroenterol 2007; 42: 830–836.
61 Asare GA, Kew MC, Mossanda KS, Paterson AC, Siziba K, Kahler-Venter
CP. Effects of exogenous antioxidants on dietary iron overload. J Clin
Biochem Nutr 2009; 44: 85–94.